Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1718171000168115 | inert substance diluent [1 x 2 mL syringe] (&) octreotide 30 mg modified release injection [1 x 30 mg vial], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1718181000168117 | octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | has MPUU | octreotide 30 mg modified release injection, vial | true | Inferred relationship | Some | 1 | |
| octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | has MPUU | inert substance diluent, 2 mL syringe | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Octreotide Depot (Teva) (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Is a | True | octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | Inferred relationship | Some | |
| Sandostatin LAR (1 x 30 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Is a | True | octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR